NAVIDEA BIOPHARMACEUTICALS INC Chart calendar Navidea Biopharmaceuticals Inc
9506c5edadaec2b1c35eacb.lqighjVYe4oqHj4bRzqBz8t1LSdEAHfDj89zRt9dAxk.xf7M8nYrH9BaJ0ciIlnVraEjWAoIWBGKuL4_cJZucXL05cWxYC0c-FJfXQ~837dc24b450f81ef47e527a55bd2df68
Upcoming events on Navidea Biopharmaceuticals Inc
Past events on Navidea Biopharmaceuticals Inc
| 2023-11-16 01:00 pm | Annual General Meeting |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-07-27 01:00 pm | Extraordinary Shareholders Meeting |
| 2023-06-07 04:00 pm | Q1 2023 Earnings Release |
| 2023-03-21 05:00 pm | Q4 2022 Earnings Call |
| 2023-03-21 04:01 pm | Q4 2022 Earnings Release |
| 2022-12-08 01:00 pm | Annual General Meeting |
| 2022-11-15 05:00 pm | Q3 2022 Earnings Call |
| 2022-11-14 08:00 am | Q3 2022 Earnings Release |
| 2022-11-10 09:00 am | Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161 |
| 2022-11-09 | American College of Rheumatology Convergence Conference |
| 2022-09-08 04:00 pm | Interim 2022 Earnings Call |
| 2022-08-15 08:30 am | Interim 2022 Earnings Release |
| 2022-06-11 09:00 pm | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197 |
| 2022-05-12 05:00 pm | Q1 2022 Earnings Call |
| 2022-05-12 07:30 am | Q1 2022 Earnings Release |
| 2022-04-20 05:00 pm | NAV3-32 Phase 2B Study Results Call |
| 2022-04-14 05:00 pm | Business Update Call |
| 2022-03-23 05:00 pm | FY 2021 Earnings Call |
| 2022-03-23 07:30 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,17 | 0,66 0,77 -14.18% | 0,92 0,90 2.18% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 -11,0 0.09% | -10,7 -12,1 11.2% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.17% | -10,7 -12,1 11.02% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.16% | -11,4 -12,1 5.51% |
|
EPS USD | Released Forecast Spread | -1,80 | -0,76 -0,74 -3.4% | -0,48 -0,48 0% |
| Announcement Date | - | 11/03/20 | 24/03/21 |
Quarterly results
| Fiscal Period | December | 2021 Q3 |
|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
|
Net income Million USD | Released Forecast Spread | -2,44 -3,52 30.8% |
|
EPS USD | Released Forecast Spread | -0,08 -0,11 27.27% |
| Announcement Date | 10/11/21 |
More events
Past sector events for Navidea Biopharmaceuticals Inc
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
